Cargando…
Study on the Clinical Safe and Effective Methods of Arsenic-Containing Compound-Qinghuang Powder in the Treatment of Myelodysplastic Syndrome
OBJECTIVE: To establish the clinical safe and effective methods of arsenic-containing compound-Qinghuang Powder (compound-QHP) in the treatment of myelodysplastic syndrome (MDS). METHODS: 200 patients with MDS were treated with compound-QHP (daily dose of 0.1 g realgar). The blood arsenic concentrat...
Autores principales: | Zhu, Qianzhe, Deng, Zhongyang, Zhu, Shirong, Zhao, Pan, Wang, Mingjing, Hu, Xiaomei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5733968/ https://www.ncbi.nlm.nih.gov/pubmed/29348764 http://dx.doi.org/10.1155/2017/2095682 |
Ejemplares similares
-
Deciphering the Key Pharmacological Pathways and Targets of Yisui Qinghuang Powder That Acts on Myelodysplastic Syndromes Using a Network Pharmacology-Based Strategy
por: Han, Zijian, et al.
Publicado: (2020) -
Effects of Qinghuang Powder on Acute Myeloid Leukemia Based on Network Pharmacology, Molecular Docking, and In Vitro Experiments
por: Zeng, Ying-jian, et al.
Publicado: (2021) -
Karyotype and DNA-Methylation Responses in Myelodysplastic Syndromes following Treatment with Traditional Chinese Formula Containing Arsenic
por: Shuzhen, Sun, et al.
Publicado: (2012) -
Arsenic Disulfide Promoted Hypomethylation by Increasing DNA Methyltransferases Expression in Myelodysplastic Syndrome
por: Zhou, Qing-Bing, et al.
Publicado: (2020) -
Using circulating tumor DNA to monitor myelodysplastic syndromes status
por: Zhao, Pan, et al.
Publicado: (2019)